SPARSENTAN

SPARSENTAN was reported 6767 times

SPARSENTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WHITE BLOOD CELLS URINE ABNORMAL 3 0.1500
1 KALEIDOSCOPE VISION 2 0.0625
2 CYSTATIN C INCREASED 6 0.0469
3 BLOOD PRESSURE ORTHOSTATIC INCREASED 1 0.0400
4 CREATININE URINE DECREASED 5 0.0316
5 PROTEIN TOTAL INCREASED 80 0.0300
6 URINARY OCCULT BLOOD POSITIVE 7 0.0298
7 GLUCOSE URINE 4 0.0267
8 BLOOD 1,25-DIHYDROXYCHOLECALCIFEROL DECREASED 2 0.0247
9 GLUCOSE URINE PRESENT 31 0.0244
10 SPECIFIC GRAVITY URINE ABNORMAL 2 0.0235
11 PROTEIN URINE PRESENT 115 0.0230
12 URINE POTASSIUM INCREASED 2 0.0230
13 BENIGN NEOPLASM OF PROSTATE 1 0.0227
14 SUSPECTED OFF LABEL USE 95 0.0210
15 PROTEIN TOTAL ABNORMAL 27 0.0207
16 GLOMERULAR FILTRATION RATE DECREASED 253 0.0206
17 URINE ABNORMALITY 92 0.0202
18 PH URINE DECREASED 2 0.0200
19 ANDROPAUSE 1 0.0192
20 CARBON DIOXIDE DECREASED 22 0.0191
21 URINARY CASTS PRESENT 2 0.0190
22 PRODUCT ADMINISTRATION ERROR 369 0.0182
23 BLOOD CHLORIDE INCREASED 28 0.0162
24 PANCREATIC ENZYMES DECREASED 2 0.0156
25 ALBUMIN GLOBULIN RATIO INCREASED 2 0.0146
26 CAFFEINE CONSUMPTION 1 0.0145
27 FAECAL OCCULT BLOOD POSITIVE 5 0.0142
28 RED BLOOD CELLS URINE POSITIVE 13 0.0134
29 ASPARTATE AMINOTRANSFERASE DECREASED 7 0.0132
30 DIZZINESS POSTURAL 128 0.0132
31 CARDIAC CONTRACTILITY DECREASED 1 0.0130
32 URINARY CASTS 5 0.0129
33 GLOMERULAR FILTRATION RATE ABNORMAL 18 0.0127
34 ALANINE AMINOTRANSFERASE DECREASED 9 0.0124
35 BLOOD CHLORIDE ABNORMAL 2 0.0123
36 ACQUIRED HYDROCELE 1 0.0120
37 BLOOD POTASSIUM INCREASED 194 0.0119
38 MUSCLE STRENGTH ABNORMAL 5 0.0119
39 DIASTOLIC HYPOTENSION 2 0.0118
40 BASOPHIL PERCENTAGE INCREASED 2 0.0114
41 BIOPSY KIDNEY 3 0.0105
42 CREATININE URINE INCREASED 3 0.0099
43 HAEMOGLOBIN URINE PRESENT 2 0.0099
44 BLOOD URINE 9 0.0093
45 METABOLIC FUNCTION TEST ABNORMAL 3 0.0091
46 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 15 0.0090
47 PROTEINURIA 166 0.0087
48 COLD FLASH 1 0.0086
49 ANION GAP DECREASED 3 0.0086
50 INCREASED NEED FOR SLEEP 2 0.0086
51 BILIRUBIN URINE PRESENT 1 0.0084
52 LIVER FUNCTION TEST DECREASED 3 0.0083
53 MEAN PLATELET VOLUME INCREASED 5 0.0083
54 GLOBULINS INCREASED 3 0.0082
55 DRUG DOSE TITRATION NOT PERFORMED 15 0.0082
56 BLOOD BILIRUBIN DECREASED 5 0.0081
57 BLOOD PRESSURE SYSTOLIC DECREASED 36 0.0079
58 ALBUMIN URINE PRESENT 3 0.0079
59 KLEBSIELLA URINARY TRACT INFECTION 2 0.0075
60 BLOOD ALKALINE PHOSPHATASE DECREASED 7 0.0074
61 ASYMPTOMATIC BACTERIURIA 1 0.0074
62 WHITE BLOOD CELLS URINE 2 0.0072
63 IMMATURE GRANULOCYTE COUNT INCREASED 2 0.0071
64 TRANSFERRIN SATURATION DECREASED 3 0.0070
65 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 2 0.0069
66 MICTURITION FREQUENCY DECREASED 5 0.0067
67 CONTRAINDICATED PRODUCT PRESCRIBED 11 0.0065
68 CARBON DIOXIDE ABNORMAL 2 0.0064
69 SEASONAL AFFECTIVE DISORDER 2 0.0063
70 BLOOD IMMUNOGLOBULIN E DECREASED 1 0.0062
71 BLOOD CREATININE ABNORMAL 21 0.0061
72 GLOMERULAR FILTRATION RATE INCREASED 5 0.0061
73 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED 1 0.0060
74 BLOOD TRIGLYCERIDES DECREASED 2 0.0059
75 WHITE BLOOD CELLS URINE POSITIVE 11 0.0058
76 BLOOD ALBUMIN ABNORMAL 3 0.0058
77 ABNORMAL MENSTRUAL CLOTS 1 0.0057
78 PROTEIN TOTAL DECREASED 21 0.0056
79 BLOOD IMMUNOGLOBULIN A INCREASED 3 0.0056
80 RENAL TRANSPLANT 20 0.0055
81 PROTEIN URINE 5 0.0055
82 BLOOD PHOSPHORUS INCREASED 15 0.0055
83 BACTERIURIA 3 0.0053
84 URINE KETONE BODY PRESENT 8 0.0051
85 VITAMIN D ABNORMAL 2 0.0049
86 VITAMIN D INCREASED 3 0.0049
87 ANGIOMYOLIPOMA 1 0.0047
88 URINARY SEDIMENT PRESENT 3 0.0047
89 COLD URTICARIA 1 0.0045
90 BACTERIAL TEST POSITIVE 10 0.0045
91 BREAST HAEMATOMA 1 0.0044
92 URINE ANALYSIS ABNORMAL 13 0.0043
93 OPHTHALMIC MIGRAINE 3 0.0043
94 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
95 BLOOD UREA ABNORMAL 4 0.0043
96 CONTRAINDICATED PRODUCT ADMINISTERED 126 0.0042
97 BLOOD CREATINE ABNORMAL 2 0.0041
98 EXERCISE LACK OF 2 0.0041
99 BLOOD PARATHYROID HORMONE INCREASED 12 0.0041
100 BLOOD URIC ACID DECREASED 2 0.0041
101 BLOOD UREA INCREASED 68 0.0041
102 BLOOD PRESSURE DECREASED 268 0.0040
103 GASTRIC PH DECREASED 4 0.0039
104 FEMALE STERILISATION 2 0.0039
105 BLOOD CREATINE INCREASED 17 0.0038
106 BASOPHIL COUNT DECREASED 1 0.0038
107 HYPOTENSION 750 0.0037
108 RENAL PAIN 39 0.0037
109 CHROMATURIA 83 0.0037
110 IGA NEPHROPATHY 6 0.0036
111 LIVER FUNCTION TEST INCREASED 74 0.0034
112 BLOOD CREATININE INCREASED 221 0.0034
113 URINE FLOW DECREASED 8 0.0033
114 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
115 PRODUCT USED FOR UNKNOWN INDICATION 4 0.0032
116 GOUT 56 0.0031
117 DRUG EFFECT LESS THAN EXPECTED 46 0.0031
118 RENAL SURGERY 2 0.0031
119 BLOOD POTASSIUM ABNORMAL 8 0.0030
120 CYST RUPTURE 2 0.0029
121 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
122 STEROID WITHDRAWAL SYNDROME 3 0.0029
123 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
124 PUNCTURE SITE HAEMORRHAGE 2 0.0028
125 BLOOD URIC ACID INCREASED 16 0.0028
126 MENOPAUSE 7 0.0027
127 TUNNEL VISION 5 0.0027
128 BLOOD PRESSURE ABNORMAL 53 0.0027
129 BREAST RECONSTRUCTION 1 0.0027
130 DIZZINESS EXERTIONAL 2 0.0026
131 FLANK PAIN 24 0.0026
132 BLOOD CREATININE DECREASED 8 0.0026
133 LABORATORY TEST ABNORMAL 74 0.0025
134 MAMMOPLASTY 2 0.0025
135 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4 0.0025
136 BLOOD URIC ACID ABNORMAL 1 0.0025
137 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
138 TONGUE ERYTHEMA 2 0.0024
139 OESOPHAGEAL PERFORATION 2 0.0024
140 CARDITIS 1 0.0024
141 HYPERAESTHESIA TEETH 3 0.0024
142 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 2 0.0024
143 MUSCLE FATIGUE 10 0.0024
144 HEPATIC PAIN 10 0.0023
145 HYPERKALAEMIA 81 0.0023
146 PERIPHERAL SWELLING 354 0.0023
147 BLOOD ALBUMIN INCREASED 2 0.0022
148 ANION GAP INCREASED 3 0.0022
149 BLOOD URINE PRESENT 42 0.0022
150 RENAL FUNCTION TEST ABNORMAL 10 0.0022
151 PERIORBITAL SWELLING 12 0.0021
152 DIALYSIS 30 0.0021
153 BLOOD BICARBONATE DECREASED 4 0.0021
154 BRAIN FOG 33 0.0021
155 FLUID RETENTION 105 0.0021
156 RENAL IMPAIRMENT 173 0.0021
157 EYELID RASH 2 0.0020
158 NEPHRECTOMY 3 0.0020
159 DIZZINESS 984 0.0020
160 BREAST CANCER MALE 1 0.0020
161 URINE OUTPUT DECREASED 17 0.0019
162 URINE OUTPUT INCREASED 5 0.0019
163 ORTHOSTATIC HYPOTENSION 33 0.0019
164 ALBUMINURIA 1 0.0019
165 URINE ODOUR ABNORMAL 11 0.0019
166 CUSHINGOID 6 0.0019
167 COLONOSCOPY 4 0.0018
168 MEAN CELL HAEMOGLOBIN INCREASED 3 0.0018
169 TONSILLECTOMY 3 0.0018
170 TONSILLAR DISORDER 2 0.0018
171 HAEMATOCRIT INCREASED 4 0.0018
172 BLOOD PRESSURE FLUCTUATION 42 0.0017
173 KIDNEY FIBROSIS 3 0.0017
174 VERTIGO POSITIONAL 3 0.0017
175 ROTATOR CUFF REPAIR 3 0.0017
176 CARDIAC ABLATION 3 0.0017
177 HEPATIC ENZYME INCREASED 114 0.0017
178 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0017
179 BLOOD VISCOSITY INCREASED 1 0.0017
180 ALLERGY TO METALS 1 0.0016
181 BLOOD PHOSPHORUS DECREASED 6 0.0016
182 OTITIS EXTERNA 2 0.0016
183 ASPARTATE AMINOTRANSFERASE INCREASED 86 0.0016
184 GENERALISED OEDEMA 20 0.0016
185 ARTHRITIS REACTIVE 1 0.0016
186 HYPERPARATHYROIDISM SECONDARY 4 0.0016
187 BLOOD PARATHYROID HORMONE ABNORMAL 1 0.0016
188 HUNGER 22 0.0016
189 PRODUCT USE IN UNAPPROVED INDICATION 390 0.0016
190 HERNIA REPAIR 4 0.0015
191 LYMPHOCYTE COUNT INCREASED 5 0.0015
192 ENERGY INCREASED 9 0.0015
193 ILLNESS 157 0.0015
194 PRESYNCOPE 37 0.0015
195 BLOOD IRON DECREASED 18 0.0015
196 BLOOD ALBUMIN DECREASED 12 0.0015
197 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
198 BRONCHITIS VIRAL 1 0.0015
199 POLLAKIURIA 62 0.0015
200 ALANINE AMINOTRANSFERASE INCREASED 91 0.0015
201 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
202 GLYCOSURIA 2 0.0015
203 JOINT SWELLING 178 0.0015
204 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
205 ASTHENOPIA 8 0.0015
206 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
207 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
208 PRESCRIBED UNDERDOSE 28 0.0014
209 NOROVIRUS INFECTION 2 0.0014
210 RED BLOOD CELL COUNT DECREASED 39 0.0014
211 ARTERIAL INJURY 1 0.0013
212 BASOPHIL COUNT INCREASED 1 0.0013
213 ABDOMINAL HERNIA 6 0.0013
214 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
215 OEDEMA 71 0.0013
216 ASPIRATION PLEURAL CAVITY 1 0.0013
217 ALLERGIC COUGH 1 0.0013
218 PRODUCT RESIDUE PRESENT 7 0.0013
219 MEAN CELL VOLUME DECREASED 2 0.0013
220 THIRST 23 0.0013
221 VITAMIN D DECREASED 11 0.0013
222 PRURITUS GENITAL 3 0.0013
223 GASTROENTERITIS VIRAL 23 0.0013
224 WRONG DOSE 3 0.0012
225 ABDOMINAL SYMPTOM 1 0.0012
226 HAEMATOLOGICAL INFECTION 3 0.0012
227 HAEMATOCRIT DECREASED 24 0.0012
228 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
229 CARDIAC STRESS TEST ABNORMAL 1 0.0012
230 BLOOD CALCIUM ABNORMAL 2 0.0012
231 MEDICAL PROCEDURE 2 0.0012
232 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
233 TYMPANIC MEMBRANE PERFORATION 2 0.0012
234 POOR PERIPHERAL CIRCULATION 5 0.0012
235 MEAN CELL VOLUME INCREASED 3 0.0012
236 BLOOD CHLORIDE DECREASED 3 0.0012
237 BLOOD CALCIUM DECREASED 13 0.0012
238 PERIORBITAL OEDEMA 6 0.0012
239 POLYMENORRHOEA 4 0.0012
240 SWELLING FACE 75 0.0012
241 FATIGUE 887 0.0011
242 NASAL DISORDER 3 0.0011
243 BLOOD SODIUM INCREASED 3 0.0011
244 BLOOD MAGNESIUM INCREASED 1 0.0011
245 ANAEMIA OF CHRONIC DISEASE 1 0.0011
246 PNEUMOMEDIASTINUM 2 0.0011
247 HAEMOGLOBIN INCREASED 5 0.0011
248 CERUMEN IMPACTION 1 0.0011
249 RHINALGIA 3 0.0011
250 LOCALISED OEDEMA 5 0.0011
251 BIOPSY 1 0.0011
252 SLUGGISHNESS 11 0.0011
253 NOCTURIA 13 0.0011
254 YELLOW SKIN 5 0.0011
255 ABDOMINAL DISCOMFORT 178 0.0011
256 APPETITE DISORDER 7 0.0011
257 PANCREATIC CYST 2 0.0010
258 OEDEMA PERIPHERAL 127 0.0010
259 GINGIVAL RECESSION 2 0.0010
260 MOTION SICKNESS 2 0.0010
261 MUSCULOSKELETAL CHEST PAIN 16 0.0010
262 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
263 POOR QUALITY SLEEP 22 0.0010
264 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
265 SEASONAL ALLERGY 14 0.0010
266 EAR HAEMORRHAGE 2 0.0010
267 HYPERTENSION 209 0.0010
268 EYELID PAIN 2 0.0010
269 ARTHRODESIS 1 0.0010
270 BLOOD PRESSURE INCREASED 149 0.0010
271 RENAL MASS 2 0.0010
272 VARICOSE VEIN 5 0.0010
273 MENSTRUAL DISORDER 8 0.0010
274 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
275 NASOPHARYNGITIS 177 0.0010
276 HEAD DISCOMFORT 17 0.0010
277 DYSPEPSIA 94 0.0010
278 BLOOD SODIUM DECREASED 18 0.0010
279 NASAL CONGESTION 56 0.0010
280 CARPAL TUNNEL DECOMPRESSION 1 0.0009
281 SENSITIVE SKIN 7 0.0009
282 TESTICULAR PAIN 3 0.0009
283 PRODUCT DOSE OMISSION ISSUE 278 0.0009
284 SWELLING 88 0.0009
285 ALLERGY TO ANIMAL 1 0.0009
286 FOOD POISONING 5 0.0009
287 TENSION HEADACHE 4 0.0009
288 OCULAR ICTERUS 4 0.0009
289 GASTRIC BYPASS 2 0.0009
290 ABDOMINAL PAIN UPPER 189 0.0009
291 OLIGOMENORRHOEA 2 0.0009
292 LIMB DISCOMFORT 28 0.0009
293 FAECES PALE 2 0.0009
294 NEPHRITIS 3 0.0009
295 EAR DISCOMFORT 9 0.0009
296 BLOODY DISCHARGE 1 0.0009
297 NEPHROTIC SYNDROME 6 0.0009
298 SKIN ATROPHY 5 0.0009
299 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
300 HYPOPNOEA 3 0.0009
301 BILIRUBIN CONJUGATED INCREASED 2 0.0009
302 ORAL SURGERY 2 0.0009
303 ESCHERICHIA BACTERAEMIA 2 0.0008
304 COCCIDIOIDOMYCOSIS 1 0.0008
305 PULSE ABNORMAL 2 0.0008
306 LYMPHADENITIS 2 0.0008
307 LIVER FUNCTION TEST ABNORMAL 24 0.0008
308 PRURITUS 317 0.0008
309 AMYLASE INCREASED 3 0.0008
310 PIGMENTATION DISORDER 5 0.0008
311 HYPERVOLAEMIA 4 0.0008
312 MUSCLE STRAIN 7 0.0008
313 BLADDER DISCOMFORT 1 0.0008
314 AORTIC VALVE REPLACEMENT 1 0.0008
315 RENAL DISORDER 37 0.0008
316 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
317 INFLUENZA 88 0.0008
318 GASTRIC INFECTION 3 0.0008
319 BLOOD TEST ABNORMAL 11 0.0008
320 BLOOD BILIRUBIN ABNORMAL 1 0.0008
321 ABNORMAL UTERINE BLEEDING 2 0.0008
322 FOOD ALLERGY 6 0.0008
323 APGAR SCORE LOW 1 0.0008
324 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
325 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
326 SOMNOLENCE 156 0.0008
327 FAECES HARD 3 0.0008
328 RHINOVIRUS INFECTION 3 0.0008
329 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
330 POLYDIPSIA 3 0.0008
331 GASTROOESOPHAGEAL REFLUX DISEASE 61 0.0008
332 DEHYDRATION 101 0.0008
333 MUSCULOSKELETAL DISCOMFORT 13 0.0008
334 EAR INFECTION 20 0.0008
335 ABDOMINAL PAIN LOWER 19 0.0008
336 WHITE BLOOD CELL DISORDER 2 0.0007
337 ABDOMINAL MASS 2 0.0007
338 MUSCLE SPASMS 137 0.0007
339 PHARYNGITIS STREPTOCOCCAL 8 0.0007
340 RASH PRURITIC 40 0.0007
341 ABDOMINAL DISTENSION 77 0.0007
342 LIP BLISTER 2 0.0007
343 HYPOMENORRHOEA 2 0.0007
344 RED BLOOD CELL COUNT INCREASED 2 0.0007
345 WEIGHT INCREASED 161 0.0007
346 INTERMENSTRUAL BLEEDING 4 0.0007
347 FACE OEDEMA 12 0.0007
348 PAPULE 5 0.0007
349 APPENDIX DISORDER 1 0.0007
350 FEELING ABNORMAL 169 0.0007
351 AUDITORY DISORDER 1 0.0007
352 SHOULDER OPERATION 3 0.0007
353 HEART VALVE INCOMPETENCE 2 0.0007
354 ABNORMAL SENSATION IN EYE 3 0.0007
355 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
356 VITAMIN B12 DECREASED 2 0.0007
357 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
358 BILIARY COLIC 2 0.0007
359 FAECES SOFT 5 0.0007
360 TONGUE DISCOLOURATION 3 0.0007
361 INCREASED APPETITE 13 0.0007
362 ANKLE OPERATION 1 0.0007
363 ATYPICAL PNEUMONIA 2 0.0007
364 SYMPTOM RECURRENCE 4 0.0007
365 IRON DEFICIENCY 3 0.0007
366 HEAVY MENSTRUAL BLEEDING 6 0.0007
367 HEART RATE INCREASED 66 0.0007
368 ASTIGMATISM 1 0.0007
369 END STAGE RENAL DISEASE 12 0.0007
370 PRODUCT DISTRIBUTION ISSUE 6 0.0006
371 COAGULATION TIME PROLONGED 1 0.0006
372 APHONIA 9 0.0006
373 HEADACHE 403 0.0006
374 DRY MOUTH 52 0.0006
375 SKIN TIGHTNESS 3 0.0006
376 DECREASED APPETITE 148 0.0006
377 SWELLING OF EYELID 4 0.0006
378 BLEPHAROSPASM 4 0.0006
379 FOREIGN BODY IN THROAT 2 0.0006
380 BACK PAIN 146 0.0006
381 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
382 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
383 FRUSTRATION TOLERANCE DECREASED 5 0.0006
384 GASTROENTERITIS 9 0.0006
385 MICTURITION URGENCY 7 0.0006
386 HICCUPS 5 0.0006
387 HOSPITALISATION 93 0.0006
388 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
389 DRUG TOLERANCE 3 0.0006
390 INITIAL INSOMNIA 6 0.0006
391 CARDIAC OPERATION 5 0.0006
392 PALPITATIONS 68 0.0006
393 SNEEZING 13 0.0006
394 NAUSEA 455 0.0006
395 BREAST DISCHARGE 1 0.0006
396 HEART RATE DECREASED 20 0.0006
397 HANGOVER 2 0.0006
398 HAEMOGLOBIN DECREASED 58 0.0006
399 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
400 KIDNEY INFECTION 11 0.0006
401 CUTANEOUS VASCULITIS 2 0.0005
402 OCULAR HYPERAEMIA 26 0.0005
403 ARTHROPOD BITE 4 0.0005
404 HEART RATE ABNORMAL 3 0.0005
405 TENDON INJURY 2 0.0005
406 BLOOD CHOLESTEROL DECREASED 1 0.0005
407 OCULAR DISCOMFORT 6 0.0005
408 BLADDER SPASM 1 0.0005
409 THROAT CLEARING 2 0.0005
410 BLOOD IRON INCREASED 1 0.0005
411 CHRONIC SINUSITIS 2 0.0005
412 PHOTOPHOBIA 10 0.0005
413 TOOTH INFECTION 7 0.0005
414 HEPATIC NECROSIS 2 0.0005
415 SNORING 2 0.0005
416 OFF LABEL USE 456 0.0005
417 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
418 DYSURIA 19 0.0005
419 COUGH 144 0.0005
420 AUTOIMMUNE DISORDER 5 0.0005
421 EPIGASTRIC DISCOMFORT 2 0.0005
422 HYPERCHLORHYDRIA 3 0.0005
423 SKIN ODOUR ABNORMAL 2 0.0005
424 SINUS DISORDER 10 0.0005
425 FURUNCLE 4 0.0005
426 RENAL CYST 4 0.0005
427 HYPERPHAGIA 2 0.0005
428 BLOOD POTASSIUM DECREASED 15 0.0005
429 SKIN PAPILLOMA 2 0.0005
430 CONTUSION 48 0.0005
431 OROPHARYNGEAL PAIN 46 0.0005
432 LOCALISED INFECTION 12 0.0005
433 INGUINAL HERNIA 3 0.0005
434 TASTE DISORDER 10 0.0005
435 NEUTROPHIL COUNT INCREASED 5 0.0005
436 ABNORMAL FAECES 4 0.0005
437 ACNE 37 0.0005
438 ANAEMIA 93 0.0005
439 SPINAL STENOSIS 2 0.0005
440 EYE SWELLING 18 0.0005
441 PHARYNGITIS 6 0.0005
442 OLIGURIA 3 0.0005
443 ANAL PRURITUS 1 0.0005
444 FLATULENCE 27 0.0005
445 SLEEP TERROR 2 0.0005
446 VISION BLURRED 65 0.0005
447 PARAESTHESIA 74 0.0005
448 EXTRA DOSE ADMINISTERED 19 0.0005
449 INTERVERTEBRAL DISC DISORDER 2 0.0005
450 HYPOAESTHESIA 70 0.0005
451 SKIN HYPERPIGMENTATION 4 0.0005
452 ERUCTATION 9 0.0005
453 CHAPPED LIPS 2 0.0005
454 ADVERSE DRUG REACTION 41 0.0005
455 BLOOD CALCIUM INCREASED 4 0.0005
456 PULMONARY CONGESTION 6 0.0005
457 GINGIVAL SWELLING 2 0.0005
458 LIGAMENT RUPTURE 2 0.0005
459 ACCIDENT AT WORK 1 0.0005
460 URINARY TRACT INFECTION 77 0.0005
461 BLOOD CHOLESTEROL INCREASED 21 0.0005
462 DRUG INTOLERANCE 43 0.0004
463 DRY SKIN 59 0.0004
464 BLOOD LOSS ANAEMIA 1 0.0004
465 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
466 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
467 ASTHENIA 163 0.0004
468 NERVE COMPRESSION 4 0.0004
469 LARGE INTESTINE POLYP 3 0.0004
470 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
471 MUSCLE TIGHTNESS 7 0.0004
472 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
473 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 87 0.0004
474 HEPATIC FUNCTION ABNORMAL 16 0.0004
475 SLEEP DISORDER 30 0.0004
476 PHOTOSENSITIVITY REACTION 7 0.0004
477 PRODUCT SUPPLY ISSUE 3 0.0004
478 SLEEP APNOEA SYNDROME 8 0.0004
479 MIGRAINE 40 0.0004
480 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
481 RHINORRHOEA 27 0.0004
482 MYALGIA 71 0.0004
483 KIDNEY TRANSPLANT REJECTION 2 0.0004
484 RASH VESICULAR 2 0.0004
485 VERTIGO 25 0.0004
486 VITAMIN D DEFICIENCY 4 0.0004
487 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
488 THERAPY CHANGE 4 0.0004
489 VOMITING 191 0.0004
490 HOSPICE CARE 4 0.0004
491 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
492 LIGAMENT SPRAIN 4 0.0004
493 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
494 SUNBURN 3 0.0004
495 RASH PAPULAR 9 0.0004
496 HEPATIC ENZYME ABNORMAL 2 0.0004
497 RASH MACULAR 14 0.0004
498 COVID-19 70 0.0004
499 PAROSMIA 3 0.0004
500 FEELING COLD 11 0.0004
501 FEEDING DISORDER 8 0.0004
502 DRY THROAT 4 0.0004
503 TOOTH ABSCESS 4 0.0004
504 BOWEL MOVEMENT IRREGULARITY 3 0.0004
505 PAIN IN EXTREMITY 115 0.0004
506 GAIT INABILITY 13 0.0004
507 BLOOD GLUCOSE INCREASED 73 0.0004
508 ARTHRALGIA 159 0.0004
509 PRODUCT USE COMPLAINT 6 0.0004
510 ORAL CANDIDIASIS 5 0.0004
511 HAEMATURIA 13 0.0004
512 FULL BLOOD COUNT ABNORMAL 4 0.0004
513 HEPATIC STEATOSIS 7 0.0004
514 NECK PAIN 21 0.0004
515 RETCHING 8 0.0004
516 BLOOD GLUCOSE DECREASED 18 0.0004
517 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
518 MENSTRUATION IRREGULAR 10 0.0004
519 OVERWEIGHT 2 0.0004
520 BREAST SWELLING 1 0.0004
521 CHEST DISCOMFORT 38 0.0004
522 DECREASED ACTIVITY 4 0.0004
523 NEURALGIA 9 0.0004
524 FAECES DISCOLOURED 8 0.0004
525 HERNIA 7 0.0004
526 HEPATOTOXICITY 8 0.0004
527 HAEMORRHOIDS 7 0.0004
528 EYE PRURITUS 12 0.0004
529 PRODUCT AVAILABILITY ISSUE 8 0.0004
530 INTENTIONAL DOSE OMISSION 10 0.0004
531 HYPERSENSITIVITY 65 0.0003
532 CHOLECYSTECTOMY 4 0.0003
533 INTERNAL HAEMORRHAGE 4 0.0003
534 NEPHROLITHIASIS 16 0.0003
535 CORONARY ARTERY BYPASS 2 0.0003
536 EXERCISE TOLERANCE DECREASED 2 0.0003
537 WEIGHT DECREASED 97 0.0003
538 HYSTERECTOMY 3 0.0003
539 SKIN SWELLING 3 0.0003
540 HYPOKINESIA 5 0.0003
541 IMMUNOSUPPRESSION 3 0.0003
542 LYMPHOCYTE COUNT DECREASED 6 0.0003
543 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
544 CATARACT OPERATION 2 0.0003
545 SINUS HEADACHE 2 0.0003
546 ANAL INCONTINENCE 3 0.0003
547 FREQUENT BOWEL MOVEMENTS 9 0.0003
548 OROPHARYNGEAL DISCOMFORT 3 0.0003
549 HYPOAESTHESIA ORAL 5 0.0003
550 LIMB INJURY 9 0.0003
551 MALAISE 145 0.0003
552 INJECTION SITE VESICLES 2 0.0003
553 PANIC ATTACK 12 0.0003
554 FOETAL GROWTH RESTRICTION 2 0.0003
555 NERVOUSNESS 17 0.0003
556 IRON DEFICIENCY ANAEMIA 3 0.0003
557 BLOOD GLUCOSE ABNORMAL 6 0.0003
558 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
559 BONE PAIN 19 0.0003
560 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
561 TOOTH EXTRACTION 4 0.0003
562 NEPHROPATHY 3 0.0003
563 BLOOD BLISTER 1 0.0003
564 NASAL DRYNESS 2 0.0003
565 INSOMNIA 85 0.0003
566 CHEST PAIN 59 0.0003
567 HOT FLUSH 24 0.0003
568 PHOTOPSIA 2 0.0003
569 MUSCLE ATROPHY 4 0.0003
570 TRANSAMINASES INCREASED 7 0.0003
571 TOOTH DISORDER 7 0.0003
572 DYSPNOEA 178 0.0003
573 HYPERSOMNIA 9 0.0003
574 ACUTE KIDNEY INJURY 48 0.0003
575 SCIATICA 5 0.0003
576 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
577 HAEMOGLOBIN ABNORMAL 2 0.0003
578 FEELING HOT 19 0.0003
579 DYSGEUSIA 23 0.0003
580 CARDIAC FLUTTER 2 0.0003
581 ORAL HERPES 6 0.0003
582 CHILLS 36 0.0003
583 PHARYNGEAL SWELLING 3 0.0003
584 ABDOMINAL PAIN 71 0.0003
585 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 55 0.0003
586 IMMUNE SYSTEM DISORDER 4 0.0003
587 SINUSITIS 31 0.0003
588 HYPOTONIA 3 0.0003
589 POST-TRAUMATIC STRESS DISORDER 2 0.0003
590 IMPAIRED GASTRIC EMPTYING 4 0.0003
591 ABNORMAL LOSS OF WEIGHT 2 0.0003
592 BLOOD TESTOSTERONE DECREASED 2 0.0003
593 EYE MOVEMENT DISORDER 2 0.0003
594 TEMPERATURE INTOLERANCE 3 0.0003
595 GASTROINTESTINAL DISORDER 26 0.0003
596 RESPIRATION ABNORMAL 2 0.0003
597 HAIR GROWTH ABNORMAL 2 0.0003
598 CAROTID ARTERY STENOSIS 1 0.0003
599 CARPAL TUNNEL SYNDROME 4 0.0003
600 AMENORRHOEA 5 0.0003
601 SCRATCH 3 0.0003
602 COLD SWEAT 5 0.0003
603 TINNITUS 13 0.0003
604 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
605 ADVERSE EVENT 26 0.0003
606 APPENDICECTOMY 1 0.0003
607 GALLBLADDER DISORDER 5 0.0003
608 LETHARGY 16 0.0003
609 RASH 121 0.0003
610 TOOTHACHE 5 0.0003
611 BACK INJURY 3 0.0003
612 CONSTIPATION 60 0.0003
613 DYSSTASIA 8 0.0003
614 BLOOD GLUCOSE FLUCTUATION 3 0.0003
615 EYE DISORDER 9 0.0003
616 LOSS OF CONSCIOUSNESS 35 0.0003
617 INFLAMMATION 14 0.0003
618 BLINDNESS TRANSIENT 2 0.0003
619 HYPOPHOSPHATAEMIA 2 0.0003
620 VIRAL INFECTION 9 0.0003
621 FUNGAL INFECTION 9 0.0003
622 SKIN HAEMORRHAGE 4 0.0003
623 HYPERTENSIVE CRISIS 3 0.0003
624 CONJUNCTIVITIS 5 0.0003
625 FEELING DRUNK 2 0.0003
626 BONE DENSITY ABNORMAL 1 0.0003
627 ECZEMA 14 0.0003
628 HYDRONEPHROSIS 2 0.0003
629 DYSPNOEA EXERTIONAL 10 0.0003
630 LACRIMATION INCREASED 8 0.0003
631 FEELING JITTERY 5 0.0003
632 LIPASE INCREASED 2 0.0003
633 THYROID DISORDER 4 0.0003
634 TENDONITIS 4 0.0003
635 ELECTROLYTE IMBALANCE 3 0.0003
636 HYPOALBUMINAEMIA 2 0.0003
637 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
638 HAEMATOCHEZIA 14 0.0003
639 DIVERTICULITIS 7 0.0003
640 DIARRHOEA 163 0.0003
641 NASAL DISCOMFORT 2 0.0003
642 PRODUCT PRESCRIBING ERROR 6 0.0003
643 AZOTAEMIA 1 0.0003
644 SYNCOPE 25 0.0002
645 TRANSPLANT REJECTION 2 0.0002
646 BLOOD DISORDER 2 0.0002
647 NIGHT SWEATS 8 0.0002
648 STENT PLACEMENT 2 0.0002
649 ILL-DEFINED DISORDER 15 0.0002
650 DISCOMFORT 15 0.0002
651 LIVER INJURY 6 0.0002
652 POLYURIA 2 0.0002
653 SPINAL OPERATION 3 0.0002
654 ESCHERICHIA INFECTION 2 0.0002
655 INFLUENZA LIKE ILLNESS 20 0.0002
656 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
657 ARTHRITIS 19 0.0002
658 MEMORY IMPAIRMENT 33 0.0002
659 MUSCULOSKELETAL STIFFNESS 21 0.0002
660 ALOPECIA 47 0.0002
661 DERMATITIS ALLERGIC 3 0.0002
662 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
663 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
664 AORTIC VALVE INCOMPETENCE 1 0.0002
665 ABSCESS LIMB 1 0.0002
666 FACIAL PARALYSIS 2 0.0002
667 JOINT INJURY 5 0.0002
668 VISUAL IMPAIRMENT 29 0.0002
669 ERECTILE DYSFUNCTION 6 0.0002
670 BLOOD MAGNESIUM DECREASED 2 0.0002
671 NIGHTMARE 8 0.0002
672 PRODUCT PRESCRIBING ISSUE 5 0.0002
673 MUSCULAR WEAKNESS 26 0.0002
674 JOINT STIFFNESS 6 0.0002
675 ADVERSE REACTION 3 0.0002
676 PURPURA 2 0.0002
677 CATHETERISATION CARDIAC 1 0.0002
678 LIVER DISORDER 10 0.0002
679 EXPOSURE DURING PREGNANCY 14 0.0002
680 HYPERHIDROSIS 29 0.0002
681 EYE HAEMORRHAGE 3 0.0002
682 BLOOD BILIRUBIN INCREASED 6 0.0002
683 HEAD INJURY 7 0.0002
684 URTICARIA 37 0.0002
685 MOOD ALTERED 6 0.0002
686 RESTLESS LEGS SYNDROME 4 0.0002
687 GINGIVAL BLEEDING 3 0.0002
688 MOOD SWINGS 7 0.0002
689 SKIN LESION 6 0.0002
690 BRAIN NEOPLASM 2 0.0002
691 FLUSHING 22 0.0002
692 ARTHRITIS INFECTIVE 1 0.0002
693 PAIN 132 0.0002
694 APPENDICITIS 2 0.0002
695 HEPATIC CIRRHOSIS 4 0.0002
696 ABORTION INDUCED 2 0.0002
697 COLITIS MICROSCOPIC 1 0.0002
698 FOOT FRACTURE 4 0.0002
699 PRODUCT PACKAGING ISSUE 2 0.0002
700 GASTRIC ULCER 4 0.0002
701 EYE INFLAMMATION 2 0.0002
702 DEPRESSED MOOD 11 0.0002
703 PARAESTHESIA ORAL 3 0.0002
704 EAR PAIN 4 0.0002
705 APATHY 3 0.0002
706 DYSPHONIA 12 0.0002
707 SURGERY 12 0.0002
708 DISTURBANCE IN ATTENTION 11 0.0002
709 ANXIETY 58 0.0002
710 HEPATOMEGALY 2 0.0002
711 KNEE OPERATION 2 0.0002
712 BRONCHITIS 15 0.0002
713 DISORIENTATION 8 0.0002
714 ANEURYSM 1 0.0002
715 RESPIRATORY DISORDER 6 0.0002
716 AGEUSIA 5 0.0002
717 BLINDNESS 8 0.0002
718 SKIN DISCOLOURATION 9 0.0002
719 EUPHORIC MOOD 2 0.0002
720 ANKLE FRACTURE 3 0.0002
721 PYREXIA 67 0.0002
722 DIPLOPIA 5 0.0002
723 EYE DISCHARGE 2 0.0002
724 DRUG-INDUCED LIVER INJURY 6 0.0002
725 RESPIRATORY TRACT CONGESTION 3 0.0002
726 PRODUCTIVE COUGH 9 0.0002
727 RASH ERYTHEMATOUS 9 0.0002
728 COMPRESSION FRACTURE 1 0.0002
729 JAUNDICE 5 0.0002
730 ANAL ABSCESS 1 0.0002
731 BRUXISM 1 0.0002
732 PRODUCT DISPENSING ERROR 4 0.0002
733 OESOPHAGITIS 2 0.0002
734 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
735 IRRITABILITY 11 0.0002
736 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
737 ANGIOEDEMA 8 0.0002
738 DRY EYE 9 0.0002
739 NERVE INJURY 2 0.0002
740 PULMONARY OEDEMA 8 0.0002
741 CELLULITIS 9 0.0002
742 THROAT IRRITATION 8 0.0002
743 SKIN INFECTION 2 0.0002
744 BLISTER 10 0.0002
745 CANDIDA INFECTION 3 0.0002
746 ANGER 6 0.0002
747 EYE INFECTION 2 0.0002
748 REBOUND EFFECT 2 0.0002
749 MITRAL VALVE INCOMPETENCE 2 0.0002
750 DERMATITIS CONTACT 2 0.0002
751 DRUG INEFFECTIVE 231 0.0002
752 ERYTHEMA 36 0.0002
753 CARDIAC VALVE DISEASE 1 0.0002
754 HERPES ZOSTER 10 0.0002
755 RENAL FAILURE 23 0.0002
756 PERICARDIAL EFFUSION 4 0.0002
757 VASCULITIS 2 0.0002
758 BRADYKINESIA 1 0.0002
759 URINARY INCONTINENCE 5 0.0002
760 BACTERAEMIA 2 0.0002
761 CHOLECYSTITIS 2 0.0002
762 ACCIDENT 2 0.0002
763 GAIT DISTURBANCE 32 0.0002
764 OSTEOMYELITIS 3 0.0002
765 FALL 55 0.0002
766 PNEUMONIA 53 0.0002
767 SMALL INTESTINAL OBSTRUCTION 2 0.0002
768 BALANCE DISORDER 14 0.0002
769 CYST 2 0.0002
770 CHRONIC KIDNEY DISEASE 12 0.0002
771 TACHYCARDIA 14 0.0002
772 METABOLIC ACIDOSIS 5 0.0002
773 HEPATITIS 4 0.0002
774 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
775 POST PROCEDURAL COMPLICATION 3 0.0002
776 LOWER LIMB FRACTURE 3 0.0002
777 ROTATOR CUFF SYNDROME 2 0.0002
778 RESPIRATORY TRACT INFECTION 4 0.0002
779 SKIN FISSURES 3 0.0002
780 PLATELET COUNT INCREASED 2 0.0002
781 MOBILITY DECREASED 11 0.0002
782 DEAFNESS 4 0.0002
783 GASTRITIS 4 0.0002
784 WHEEZING 9 0.0002
785 DISABILITY 3 0.0002
786 DYSMENORRHOEA 2 0.0002
787 TREMOR 25 0.0002
788 LIP SWELLING 5 0.0001
789 URINARY RETENTION 5 0.0001
790 FULL BLOOD COUNT DECREASED 3 0.0001
791 SINUS CONGESTION 2 0.0001
792 RIB FRACTURE 3 0.0001
793 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
794 PERIPHERAL COLDNESS 2 0.0001
795 UNEVALUABLE EVENT 11 0.0001
796 ABNORMAL DREAMS 4 0.0001
797 ORAL DISCOMFORT 2 0.0001
798 RHABDOMYOLYSIS 6 0.0001
799 HAEMOPTYSIS 4 0.0001
800 MASS 2 0.0001
801 WOUND 4 0.0001
802 MOUTH ULCERATION 3 0.0001
803 IMPAIRED WORK ABILITY 3 0.0001
804 IMPAIRED QUALITY OF LIFE 2 0.0001
805 EYE IRRITATION 8 0.0001
806 INFECTION 20 0.0001
807 ANOSMIA 2 0.0001
808 HYPERTHYROIDISM 2 0.0001
809 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
810 THROMBOSIS 11 0.0001
811 THERAPY CESSATION 7 0.0001
812 CONFUSIONAL STATE 22 0.0001
813 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
814 IMMUNODEFICIENCY 2 0.0001
815 HAEMORRHAGE INTRACRANIAL 2 0.0001
816 BREAST TENDERNESS 1 0.0001
817 HEART RATE IRREGULAR 3 0.0001
818 ACIDOSIS 1 0.0001
819 HIP ARTHROPLASTY 2 0.0001
820 ATRIOVENTRICULAR BLOCK 1 0.0001
821 APHTHOUS ULCER 1 0.0001
822 SWOLLEN TONGUE 4 0.0001
823 PRODUCT USE ISSUE 24 0.0001
824 ATRIAL FLUTTER 1 0.0001
825 CONDITION AGGRAVATED 38 0.0001
826 CARDIAC FAILURE CONGESTIVE 10 0.0001
827 BACK DISORDER 2 0.0001
828 CHOLELITHIASIS 4 0.0001
829 MANIA 2 0.0001
830 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
831 ROAD TRAFFIC ACCIDENT 5 0.0001
832 SKIN EXFOLIATION 10 0.0001
833 INCORRECT DOSE ADMINISTERED 27 0.0001
834 SCAR 2 0.0001
835 HYPOACUSIS 5 0.0001
836 VAGINAL HAEMORRHAGE 5 0.0001
837 INJURY 8 0.0001
838 PANCREATITIS 6 0.0001
839 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
840 SEIZURE 13 0.0001
841 FEAR 3 0.0001
842 THROAT TIGHTNESS 3 0.0001
843 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
844 BONE DISORDER 2 0.0001
845 TREATMENT NONCOMPLIANCE 6 0.0001
846 RESTLESSNESS 4 0.0001
847 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
848 ARTHROPATHY 6 0.0001
849 DEEP VEIN THROMBOSIS 7 0.0001
850 EPISTAXIS 8 0.0001
851 OXYGEN SATURATION DECREASED 6 0.0001
852 EYE PAIN 6 0.0001
853 DYSARTHRIA 4 0.0001
854 PAIN IN JAW 3 0.0001
855 FRACTURE 2 0.0001
856 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
857 ACUTE RESPIRATORY FAILURE 2 0.0001
858 ATRIAL FIBRILLATION 10 0.0001
859 BODY TEMPERATURE DECREASED 1 0.0001
860 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
861 RENAL INJURY 3 0.0001
862 BURNING SENSATION 7 0.0001
863 PRODUCT PHYSICAL ISSUE 2 0.0001
864 CORONARY ARTERY DISEASE 3 0.0001
865 SEPSIS 11 0.0001
866 LUNG NEOPLASM MALIGNANT 4 0.0001
867 GYNAECOMASTIA 3 0.0001
868 DERMATITIS 2 0.0001
869 MUSCULOSKELETAL PAIN 5 0.0001
870 KNEE ARTHROPLASTY 2 0.0001
871 BREAST PAIN 1 0.0001
872 IRRITABLE BOWEL SYNDROME 2 0.0001
873 PSORIASIS 12 0.0001
874 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
875 HYPONATRAEMIA 5 0.0001
876 DEPRESSION 20 0.0001
877 SHOCK 2 0.0001
878 MUSCLE TWITCHING 2 0.0001
879 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
880 DYSPHAGIA 8 0.0001
881 DIABETIC KETOACIDOSIS 2 0.0001
882 CRYING 3 0.0001
883 THERAPEUTIC RESPONSE DECREASED 5 0.0001
884 ADRENAL INSUFFICIENCY 1 0.0001
885 HYPERGLYCAEMIA 3 0.0001
886 FIBROMYALGIA 2 0.0001
887 INJECTION SITE URTICARIA 2 0.0001
888 ENCEPHALOPATHY 2 0.0001
889 PNEUMONIA ASPIRATION 2 0.0001
890 COLITIS 3 0.0001
891 HAEMATEMESIS 2 0.0001
892 AMNESIA 5 0.0001
893 CEREBROVASCULAR ACCIDENT 13 0.0001
894 BEDRIDDEN 1 0.0001
895 DRUG INTERACTION 12 0.0001
896 BREAST CANCER FEMALE 2 0.0001
897 MYOCARDIAL INFARCTION 13 0.0001
898 NEUROPATHY PERIPHERAL 7 0.0001
899 PALLOR 2 0.0001
900 OSTEOPOROSIS 3 0.0001
901 PROCEDURAL PAIN 2 0.0001
902 DEMENTIA 2 0.0001
903 BLINDNESS UNILATERAL 1 0.0001
904 ASTHMA 8 0.0001
905 MENTAL DISORDER 3 0.0001
906 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
907 NEEDLE ISSUE 2 0.0001
908 CATARACT 4 0.0001
909 COLITIS ULCERATIVE 3 0.0001
910 BONE LOSS 1 0.0001
911 HEPATIC FAILURE 2 0.0001
912 SKIN IRRITATION 3 0.0001
913 DISEASE RECURRENCE 3 0.0001
914 CYSTITIS 2 0.0001
915 ABSCESS 1 0.0001
916 INJECTION SITE BRUISING 5 0.0001
917 HYPOTHYROIDISM 2 0.0001
918 HYPOGLYCAEMIA 3 0.0001
919 RHEUMATOID ARTHRITIS 7 0.0001
920 SKIN DISORDER 2 0.0001
921 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
922 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
923 SPEECH DISORDER 3 0.0001
924 LYMPHADENOPATHY 2 0.0001
925 C-REACTIVE PROTEIN INCREASED 2 0.0001
926 AGRANULOCYTOSIS 1 0.0001
927 BACTERIAL INFECTION 1 0.0001
928 CARDIAC DISORDER 5 0.0001
929 INTESTINAL OBSTRUCTION 2 0.0001
930 PULMONARY EMBOLISM 5 0.0001
931 INJECTION SITE SWELLING 4 0.0001
932 DISEASE PROGRESSION 6 0.0001
933 EMOTIONAL DISTRESS 6 0.0000
934 PLEURAL EFFUSION 3 0.0000
935 PSORIATIC ARTHROPATHY 2 0.0000
936 NEUTROPHIL COUNT DECREASED 2 0.0000
937 WITHDRAWAL SYNDROME 2 0.0000
938 OSTEOARTHRITIS 2 0.0000
939 PLATELET COUNT DECREASED 5 0.0000
940 RECTAL HAEMORRHAGE 2 0.0000
941 NEOPLASM MALIGNANT 3 0.0000
942 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
943 INJECTION SITE PRURITUS 3 0.0000
944 COGNITIVE DISORDER 2 0.0000
945 RENAL CANCER 2 0.0000
946 SKIN BURNING SENSATION 3 0.0000
947 AGITATION 3 0.0000
948 CARDIOVASCULAR DISORDER 1 0.0000
949 ANAPHYLACTIC SHOCK 1 0.0000
950 NO ADVERSE EVENT 7 0.0000
951 PROSTATE CANCER 3 0.0000
952 CARDIAC ARREST 3 0.0000
953 PANCYTOPENIA 2 0.0000
954 ANGINA PECTORIS 1 0.0000
955 ASCITES 1 0.0000
956 APHASIA 1 0.0000
957 BONE DENSITY DECREASED 1 0.0000
958 HAEMORRHAGE 3 0.0000
959 THERAPY INTERRUPTED 2 0.0000
960 CEREBRAL HAEMORRHAGE 1 0.0000
961 ACCIDENTAL OVERDOSE 1 0.0000
962 THROMBOCYTOPENIA 3 0.0000
963 DEATH 23 0.0000
964 DIABETES MELLITUS 2 0.0000
965 CARDIAC FAILURE 2 0.0000
966 TREATMENT FAILURE 2 0.0000
967 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
968 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
969 INJECTION SITE PAIN 7 0.0000
970 BREAST CANCER 2 0.0000
971 ARRHYTHMIA 1 0.0000
972 COMA 1 0.0000
973 AGGRESSION 1 0.0000
974 BRADYCARDIA 1 0.0000
975 ANAPHYLACTIC REACTION 1 0.0000
976 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
977 BLADDER CANCER 1 0.0000
978 INJECTION SITE ERYTHEMA 2 0.0000
979 COMPLETED SUICIDE 1 0.0000
980 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
981 OVERDOSE 2 0.0000